...
ARVNSMALL

Arvinas, Inc.

HealthcareBiotechnology
$13.27
$0.00(-0.82%)
52W$5.90
$18.93
Updated Mar 1, 12:00 AM
RSI58
RS Rating88/99
Beta0.99
Volatility84%
F-Score4/9
Mkt Cap$975M
STAGE 2 UPTREND

Price Action

5Y Daily
50 DMA150 DMA200 DMA

Technical Summary

STAGE 2 UPTREND

Arvinas, Inc. is in a confirmed Stage 2 uptrend, with price holding above all major moving averages and trend structure remaining intact. Relative strength is leading (RS Rating: 88), indicating clear outperformance against the broad market. Earnings contraction of 75% provides fundamental context to the price action. Investors should exercise caution due to high volatility (84% annualized), which requires wider risk management.

Relative Strength
88
out of 99
Market Leader
Trend Score
4/4
Minervini Criteria
STAGE 2 UPTREND
Risk (Beta)
0.99
vs S&P 500
MARKET
52W Position
57%
from 52W low
Mid Range
Trend & Momentum Analysis

Trend Template (Minervini)

STAGE 2 UPTREND4/4 Criteria Met
CriterionValueStatus
Price > 50 SMA$12.48
50 SMA > 100 SMA$11.66
100 SMA > 150 SMA$10.33
150 SMA > 200 SMA$9.59

Price vs Moving Averages

PeriodValueSpreadSignal
20 SMA$12.83+3.46%ABOVE
50 SMA$12.48+6.36%ABOVE
100 SMA$11.66+13.79%ABOVE
150 SMA$10.33+28.47%ABOVE
200 SMA$9.59+38.33%ABOVE

Price Performance

1D-0.8%
1W+7.9%
1M+2.6%
3M+5.4%
6M+71.0%
YTD+15.7%
1Y-25.0%
3Y-24.3%
52-Week Trading Range57% from low
$13.27
52W Low$5.90
52W High$18.93

Technical Indicators

RSI (14)NEUTRAL
58.3
305070
VCP ScoreWARM
6/10
Base depth: 23.7%

Risk Profile

Beta
0.99
52W Vol
84%
ATR
$0.83
Max DD (1Y)
-67%

Volume Analysis

Today
13
50D Avg
620.5K
Vol Ratio
0.00x
Liquidity
MODERATE

Earnings Momentum

Q1'25+218%
$1.14
Q2'25-71%
$-0.84
Q3'25+29%
$-0.48
Q4'25-75%
$-1.10
Fundamentals & Growth

Growth Trends

Compounded Sales Growth

10 Years:
5 Years:+58.93%
3 Years:+25.96%
TTM:-0.30%

Compounded Profit Growth

10 Years:
5 Years:
3 Years:
TTM:+53.79%

Stock Price CAGR

10 Years:-1.88%
5 Years:-29.70%
3 Years:-24.35%
1 Year:-25.03%

Return on Equity

10Y Avg:-56.2%
5Y Avg:-35.5%
3Y Avg:-36.3%
Last Year:-18.6%

Key Metrics

Market Cap$975M
Gross Margin-1.5%
Net Margin-30.8%
Piotroski F-Score4/9

Frequently Asked Questions

Is ARVN in an uptrend right now?

ARVN has a trend score of 4/4 based on Minervini's Stage Analysis. Yes, ARVN is in a Stage 2 uptrend with price above all major moving averages (50, 100, 150, 200 SMA) properly stacked.

Is ARVN overbought or oversold?

ARVN's RSI (14) is 58. The stock is in neutral territory, neither overbought nor oversold.

Is ARVN outperforming the market?

ARVN has a Relative Strength (RS) Rating of 88 out of 99. Yes, ARVN is a market leader, outperforming 88% of all stocks over the past 12 months.

Where is ARVN in its 52-week range?

ARVN is trading at $13.27, which is 70% of its 52-week high ($18.93) and 57% above its 52-week low ($5.90).

How volatile is ARVN?

ARVN has a Beta of 0.99 and 52-week volatility of 84%. It's less volatile than the S&P 500 - generally more stable.